Emergent BioSolutions Inc (NYSE: EBS) stock closed at $7.28 on 9/26/24 after a major increase of 22.6%. Moreover, unusually high trading volume at 168% of normal accompanied the advance. The stock has risen 5.5% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
With future capital returns forecasted to be above the cost of capital, EBS is expected to be a major Value Builder.
Emergent BioSolutions has a current Value Trend Rating of A (Highest Rating). The Value Trend Rating reflects complementary signals from PTR’s two proprietary measures of a stock’s attractiveness. Emergent BioSolutions has a slightly positive Appreciation Score of 68 and a very high Power Rating of 92, triggering the Highest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of A. This review will be completed in the next several days.
Be the first to comment